PharmStars Ventures
AcceleratorActively deployingBoston · Pre-Seed–Seed · 24 people tracked
Investment thesis
PharmStars operates an accelerator designed to bridge the gap between digital health startups and the pharmaceutical industry. Through its PharmaU educational program, it teaches startups how drugs are developed, how pharma is organized, and how the biopharma industry works, culminating in a Startup Showcase where companies present to pharma members. Cohorts are organized around themes; the Fall 2026 cohort focuses on 'Digital Innovations in Immunology,' welcoming startups with market-ready solutions in immunological disease prevention, diagnosis, treatment, and patient care. The program aims to facilitate successful startup-pharma partnerships that accelerate adoption of digital health.
Source: firm website, verified Aug 3, 2026.
Team · 24 people
from the firm's websiteWhat they invest in
from 2 of 118 portfolio companiesSaaS ×2Biotech ×1Digital Health ×1Enterprise Software ×1Healthtech ×1Marketing Tech ×1
HQs:United States×1
Portfolio companies · 118 tracked
alumni founders can tell you what the program is really likeFrequently asked questions
- What stage does PharmStars Ventures invest at?
- PharmStars Ventures invests at the Pre-Seed, Seed stages.
- What sectors does PharmStars Ventures focus on?
- PharmStars Ventures focuses on Biotech, Digital Health, Healthtech.
- Where is PharmStars Ventures located?
- PharmStars Ventures is headquartered in Boston, US.
- Does PharmStars Ventures lead rounds?
- PharmStars Ventures typically participates in rounds rather than leading them.
From the blog
visit blog ↗PharmStars has recently published content about connecting pharmaceutical companies with digital health startups to advance innovation, including insights from a Pharmatech Innovation Summit on collaboration strategies and CEO Naomi Fried's perspective on bridging the pharma-startup gap. AI summary
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan is an early-stage venture capital firm backing founders with transformative ideas across technology and healthcare.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.












.jpeg)













